JP Morgan analyst Rajat Gupta upgrades Carvana (NYSE:CVNA) from Underweight to Neutral and announces $20 price target.
Experts Weigh In On Ozempic’s Evolving Side Effects And How To Handle Them
New side effects of the ‘miracle’ weight loss drug Ozempic are emerging, causing concern among patients and healthcare professionals alike.…